137 related articles for article (PubMed ID: 15680268)
1. A reduction of endogenous asymmetric dimethylarginine contributes to the effect of captopril on endothelial dysfunction induced by homocysteine in rats.
Fu YF; Xiong Y; Guo Z
Eur J Pharmacol; 2005 Jan; 508(1-3):167-75. PubMed ID: 15680268
[TBL] [Abstract][Full Text] [Related]
2. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine.
Yin QF; Fu SH; He P; Xiong Y
Atherosclerosis; 2007 Jan; 190(1):53-61. PubMed ID: 16533509
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats.
Xiong Y; Yuan LW; Deng HW; Li YJ; Chen BM
Clin Exp Pharmacol Physiol; 2001 Oct; 28(10):842-7. PubMed ID: 11553026
[TBL] [Abstract][Full Text] [Related]
4. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
Jiang JL; Li Ns NS; Li YJ; Deng HW
Br J Pharmacol; 2002 Mar; 135(5):1175-82. PubMed ID: 11877324
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
6. The protective effect of captopril on nicotine-induced endothelial dysfunction in rat.
Luo HL; Zang WJ; Lu J; Yu XJ; Lin YX; Cao YX
Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):237-45. PubMed ID: 16930297
[TBL] [Abstract][Full Text] [Related]
7. Captopril restores endothelium-dependent relaxation of rat aortic rings after exposure to homocysteine.
Fu YF; Xiong Y; Fu SH
J Cardiovasc Pharmacol; 2003 Oct; 42(4):566-72. PubMed ID: 14508244
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level.
Tang WJ; Hu CP; Chen MF; Deng PY; Li YJ
Can J Physiol Pharmacol; 2006 Feb; 84(2):163-71. PubMed ID: 16900942
[TBL] [Abstract][Full Text] [Related]
9. Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.
Liu YH; Liu LY; Wu JX; Chen SX; Sun YX
J Cardiovasc Pharmacol; 2006 Jan; 47(1):82-8. PubMed ID: 16424790
[TBL] [Abstract][Full Text] [Related]
10. Effect of fenofibrate on LDL-induced endothelial dysfunction in rats.
Yang TL; Chen MF; Luo BL; Yu J; Jiang JL; Li YJ
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):79-83. PubMed ID: 15316718
[TBL] [Abstract][Full Text] [Related]
11. 17beta-estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
Dai Z; Zhu HQ; Jiang DJ; Jiang JL; Deng HW; Li YJ
Int J Cardiol; 2004 Aug; 96(2):223-7. PubMed ID: 15262037
[TBL] [Abstract][Full Text] [Related]
12. Relationship between protective effects of rosiglitazone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells.
Wang S; Jiang JL; Hu CP; Zhang XJ; Yang DL; Li YJ
Diabetes Metab Res Rev; 2007 Feb; 23(2):157-64. PubMed ID: 16770837
[TBL] [Abstract][Full Text] [Related]
13. Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats.
Deng S; Deng PY; Jiang JL; Ye F; Yu J; Yang TL; Deng HD; Li YJ
Acta Pharmacol Sin; 2004 Dec; 25(12):1633-9. PubMed ID: 15569408
[TBL] [Abstract][Full Text] [Related]
14. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor.
Jiang JL; Jiang DJ; Tang YH; Li NS; Deng HW; Li YJ
Acta Pharmacol Sin; 2004 Jul; 25(7):893-901. PubMed ID: 15210062
[TBL] [Abstract][Full Text] [Related]
15. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure.
Feng Q; Lu X; Fortin AJ; Pettersson A; Hedner T; Kline RL; Arnold JM
Cardiovasc Res; 1998 Mar; 37(3):667-75. PubMed ID: 9659450
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction.
Shah DI; Singh M
Vascul Pharmacol; 2006 Mar; 44(3):177-82. PubMed ID: 16442349
[TBL] [Abstract][Full Text] [Related]
17. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
Khattab MM; Mostafa A; Al-Shabanah O
Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 protects against endothelial dysfunction induced by high glucose levels in rats.
Qian LB; Wang HP; Qiu WL; Huang H; Bruce IC; Xia Q
Vascul Pharmacol; 2006 Dec; 45(6):374-82. PubMed ID: 16837248
[TBL] [Abstract][Full Text] [Related]
19. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes.
Xiong Y; Lei M; Fu S; Fu Y
Life Sci; 2005 May; 77(2):149-59. PubMed ID: 15862600
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
